Unfortunately, we cannot provide any confirmation of the results from Carapito et al. [18], who stated that the MICB-98 match reduces GVHD incidence as well as an effect of CMV on HSCT outcome, because, in our set of patients/donors, we have only five mismatches, preventing statistical analysis. Here, MICB is linked to graft versus host disease.